+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2025-2030- Product Image
Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2025-2030- Product Image
Sale

Sexually Transmitted Infection Diagnostics Kit Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081398
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior business leaders are navigating a rapidly evolving sexually transmitted infection (STI) diagnostics market, characterized by technology integration, changing regulatory frameworks, and shifting clinical demands. This report is designed to equip strategic decision-makers with the intelligence needed to act decisively in this high-stakes sector.

Market Snapshot: Outlook for the Sexually Transmitted Infection Diagnostics Market

The global landscape for STI diagnostic solutions is under unprecedented pressure and growth. Market expansion is fueled by rising infection rates, accelerating innovations in immunoassays, molecular technologies, and rapid decentralized testing platforms. As regulatory clarity improves and cross-functional partnerships strengthen, competitive differentiation hinges on product reliability, speed, and compliance with emerging guidelines. Economic drivers, including evolving tariff structures and healthcare resource allocation, further influence market positioning and supply chain strategy.

Scope & Segmentation of the STI Diagnostic Market

This report offers a broad and granular analysis of the sexually transmitted infection diagnostics market across relevant segments, geographies, technologies, and stakeholders:

  • Infection Types: Includes Chlamydia, Gonorrhea, HIV, and Syphilis—each presenting distinct testing needs and technology adoption curves.
  • Technology Modalities: Covers flow cytometry, traditional and rapid immunoassays (CLIA, ELISA), molecular diagnostics (isothermal amplification, LAMP, RPA, PCR with multiplexing and real-time capabilities), and rapid test formats (dipstick, lateral flow assays).
  • Sample Types: Encompasses testing using serum, whole blood, several swab types (endocervical, rectal, urethral, vaginal), and urine collection (first catch, midstream).
  • End Users: Focuses on clinics, diagnostic laboratories, hospital networks, and research institutes, each with unique performance requirements and throughput expectations.
  • Distribution Channels: Details direct tenders, hospital pharmacy outlets, online sales, and retail pharmacy for comprehensive market coverage.
  • Applications: Ranges from primary screening and confirmation to longitudinal infection monitoring across diverse populations.
  • Regional Analysis: Examines Americas (with states like California, Texas, New York), Europe, Middle East & Africa (including the UK, Germany, UAE, South Africa), and Asia-Pacific (countries such as China, Japan, India, Australia, and more).
  • Industry Players: Features leaders like F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Danaher, Thermo Fisher Scientific, bioMérieux, Siemens Healthineers, Quidel, and QIAGEN.

Key Takeaways for Senior Decision-Makers

  • Technology convergence is enabling a shift toward modular, scalable diagnostic platforms that integrate rapid molecular and immunoassay formats.
  • Regulatory harmonization enhances opportunities for cross-border market entry, while variable reimbursement policies shape regional go-to-market strategies.
  • Strategic partnerships are strengthening supply chain resilience and supporting innovation, especially in distributed reagent production and local manufacturing.
  • Point-of-care and decentralized testing accelerate patient triage and treatment, especially in community and outreach settings.
  • Digital health developments, such as real-time reporting and remote sample collection, increase reach and efficiency while meeting evolving patient expectations.
  • Stakeholders are enhancing sustainability by investing in AI-enabled quality controls and advanced data analytics for diagnostics.

Tariff Impact: US 2025 Policy Adjustments

Anticipated United States tariff changes for 2025 will significantly affect sourcing and pricing across diagnostic equipment, reagents, and consumables. Developers and distributors are revisiting supplier strategies by diversifying sources and pursuing domestic manufacturing. These actions are intended to buffer margin volatility, address cost escalation, and maintain competitive positioning in light of increased duties. Hospitals and laboratories, in turn, face added complexity in procurement, prompting more robust contract negotiation and inventory management practices.

Methodology & Data Sources

This report combines primary qualitative interviews with key opinion leaders from laboratories, manufacturers, and regulatory bodies, alongside an extensive secondary review of published literature and industry filings. Quantitative modeling draws from financial disclosures, procurement records, and trade datasets. All insights are validated through iterative expert workshops to ensure accuracy and actionable relevance for market leaders.

Why This Report Matters for Strategic and Investment Decisions

  • Allows executives to benchmark product and channel strategies against current technology trends, reimbursement drivers, and evolving clinical best practices.
  • Equips organizations to anticipate and respond proactively to supply chain disruptions, regulatory changes, and regional dynamics.
  • Supports resource allocation and partnership decisions grounded in clear, data-driven insights specific to the STI diagnostics sector.

Conclusion

The sexually transmitted infection diagnostics market is entering a new era shaped by rapid technological innovation, regulatory evolution, and diversified clinical requirements. Senior leaders leveraging this intelligence will be well positioned to respond agilely and drive sustainable growth in an increasingly complex healthcare environment.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of multiplex point-of-care platforms enabling simultaneous detection of multiple STIs in resource-limited settings
5.2. Integration of smartphone-based imaging and AI algorithms for automated interpretation of STI diagnostic results
5.3. Rise of self-collection kits with molecular amplification for at-home chlamydia and gonorrhea detection accuracy
5.4. Growing regulatory approvals for rapid polymerase chain reaction assays targeting emerging resistant Neisseria gonorrhoeae strains
5.5. Increasing partnerships between diagnostic manufacturers and telehealth providers to streamline remote STI testing and counseling
5.6. Advancements in CRISPR-based biosensors delivering ultrasensitive detection of low-burden Trichomonas vaginalis infections
5.7. Shift towards decentralization of STI testing with portable isothermal amplification devices in community clinics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sexually Transmitted Infection Diagnostics Kit Market, by Infection Type
8.1. Introduction
8.2. Chlamydia
8.3. Gonorrhea
8.4. HIV
8.5. Syphilis
9. Sexually Transmitted Infection Diagnostics Kit Market, by Technology
9.1. Introduction
9.2. Flow Cytometry
9.3. Immunoassay
9.3.1. CLIA
9.3.2. ELISA
9.3.3. Rapid Immunoassay
9.4. Molecular
9.4.1. Isothermal Amplification
9.4.1.1. LAMP
9.4.1.2. RPA
9.4.2. PCR
9.4.2.1. Multiplex PCR
9.4.2.2. Real Time PCR
9.5. Rapid Test
9.5.1. Dipstick
9.5.2. Lateral Flow Assay
10. Sexually Transmitted Infection Diagnostics Kit Market, by Sample Type
10.1. Introduction
10.2. Blood
10.2.1. Serum
10.2.2. Whole Blood
10.3. Swab
10.3.1. Endocervical Swab
10.3.2. Rectal Swab
10.3.3. Urethral Swab
10.3.4. Vaginal Swab
10.4. Urine
10.4.1. First Catch Urine
10.4.2. Midstream Urine
11. Sexually Transmitted Infection Diagnostics Kit Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Research Institutes
12. Sexually Transmitted Infection Diagnostics Kit Market, by Distribution Channel
12.1. Introduction
12.2. Direct Tender
12.3. Hospital Pharmacy
12.4. Online Sales
12.5. Retail Pharmacy
13. Sexually Transmitted Infection Diagnostics Kit Market, by Application
13.1. Introduction
13.2. Confirmation
13.3. Monitoring
13.4. Screening
14. Americas Sexually Transmitted Infection Diagnostics Kit Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Sexually Transmitted Infection Diagnostics Kit Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Sexually Transmitted Infection Diagnostics Kit Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd.
17.3.2. Abbott Laboratories
17.3.3. Becton, Dickinson and Company
17.3.4. Hologic, Inc.
17.3.5. Danaher Corporation
17.3.6. Thermo Fisher Scientific, Inc.
17.3.7. bioMérieux SA
17.3.8. Siemens Healthineers AG
17.3.9. Quidel Corporation
17.3.10. QIAGEN N.V.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET: RESEARCHAI
FIGURE 28. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET: RESEARCHSTATISTICS
FIGURE 29. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET: RESEARCHCONTACTS
FIGURE 30. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CHLAMYDIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY GONORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SYPHILIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY LAMP, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RPA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RPA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY REAL TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIPSTICK, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ENDOCERVICAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ENDOCERVICAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RECTAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RECTAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URETHRAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URETHRAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY VAGINAL SWAB, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY VAGINAL SWAB, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY FIRST CATCH URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY FIRST CATCH URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MIDSTREAM URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MIDSTREAM URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CONFIRMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY CONFIRMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 184. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 185. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 186. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 187. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 190. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 191. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 192. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 193. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 196. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 197. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 198. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 199. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 200. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 201. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. CANADA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 208. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 209. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 213. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 214. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 215. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 218. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 219. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 220. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 221. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 224. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 225. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 226. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 227. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. MEXICO SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY PCR, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY RAPID TEST, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY SWAB, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY INFECTION TYPE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY MOLECULAR, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA SEXUALLY TRANSMITTED INFECTION DIAGNOSTICS KIT MARKET SIZE, BY ISOTHERMAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sexually Transmitted Infection Diagnostics Kit market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • bioMérieux SA
  • Siemens Healthineers AG
  • Quidel Corporation
  • QIAGEN N.V.

Related Topics

Related Reports

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2030 - Product Image

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Sexually Transmitted Diseases (STD) Testing Global Market Report 2025 - Product Image

Sexually Transmitted Diseases (STD) Testing Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
STD Testing Market - Global Forecast 2025-2032 - Product Image

STD Testing Market - Global Forecast 2025-2032

  • Report
  • 182 Pages
  • Global
From
Sexually Transmitted Infections (STIs) Market Report 2025 - Product Image

Sexually Transmitted Infections (STIs) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033 - Product Image

Sexually Transmitted Disease Diagnostics Market Report by Type, Device Type, End User, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.